We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

New All-In-One Molecular Diagnostic System Realizes True Sample In -Result Out Detection Process

By LabMedica International staff writers
Posted on 06 Dec 2022
Print article
Image: The Panall 8000 molecular diagnostic system will be launched in the first quarter of 2023 (Photo courtesy of Tianlong)
Image: The Panall 8000 molecular diagnostic system will be launched in the first quarter of 2023 (Photo courtesy of Tianlong)

Tianlong Science and Technology (Shaanxi, China) is all set to launch its new all-in-one molecular diagnostic system in the first quarter of 2023.

Tianlong’s all-new Panall 8000 molecular diagnostic system will arrive in the market in the first quarter of 2023. The Panall 8000 is a simple and secure all-in-one molecular diagnostic system that integrates the functions of sample tube decapping/capping, sample loading, nucleic acid extraction, PCR setup, PCR detection and result analysis. This can help realize a true sample in -result out detection process and bring great convenience for professionals with only one-key operation.

The Panall 8000 offers fewer steps, walkaway workflow and high quality results. Its closed system minimizes contamination, and it allows eight samples to be inserted at the same time. It does not require any additional equipment or interpretation of results. Tianlong will be offering a testing menu for respiratory infections to be run on the Panall 8000 that will enable the detection of 17 types of respiratory pathogens, including Flu A, Flu B, RSV and SARS-CoV-2, among others.

Related Links:
Tianlong Science and Technology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.